U.S. pharma giant copyright scrapped two experimental weight loss supplements final calendar year—a at the time-day-to-day capsule, lotiglipron, due to elevated liver enzymes in addition to a two times-daily pill, danuglipron, as a consequence of solid Negative effects—but CEO Albert Bourla has stated the company is set to “Participate in and